Zevalin and cardiac failure Patient Reports February 12, 2012
Zevalin Side Effects Report #5391798-7
Zevalin side effect was reported by a Physician from POLAND on July 04, 2007. Female patient, 70 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac failure. Zevalin dosage: unknown. During the same period patient was treated with RITUXAN. Patient died on 07/01/2006.
Zevalin Side Effects Report #5504564-6
Zevalin side effect was reported by a Physician from POLAND on Oct 16, 2007. Female patient, 70 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac failure, mantle cell lymphoma recurrent, pancytopenia, shock. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient died on 07/01/2006.
Zevalin Side Effects Report #5550797-2
Zevalin side effect was reported by a Physician from POLAND on Nov 23, 2007. Female patient, 70 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acute left ventricular failure, cardiac failure, myocardial infarction, shock. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient died on 07/01/2006.
Zevalin Side Effects Report #5391799-9
Zevalin side effect was reported by a Health Professional from POLAND on July 04, 2007. Male patient, 67 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac failure, gastric ulcer haemorrhage, post procedural complication. Zevalin dosage: unknown. During the same period patient was treated with RITUXAN, FLUDARA, CYCLOPHOSPHAMIDE, MITOXANTRONE. Patient died on 08/13/2005.
Zevalin Side Effects Report #5504566-X
Zevalin side effect was reported by a Health Professional from POLAND on Oct 17, 2007. Male patient, 67 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac failure, gastric ulcer haemorrhage, malignant neoplasm progression, mantle cell lymphoma, shock. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, FLUDARA, CYCLOPHOSPHAMIDE, MITOXANTRONE. Patient died on 08/13/2005.
Zevalin Side Effects Report #5550377-9
Zevalin side effect was reported by a Health Professional from POLAND on Nov 23, 2007. Male patient, 67 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac failure, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, red blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, FLUDARA, CYCLOPHOSPHAMIDE, MITOXANTRONE. Patient died on 08/13/2005.
Zevalin Side Effects Report #5389714-7
Zevalin side effect was reported by a Physician from POLAND on July 04, 2007. Male patient, 63 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure, dehydration, lower gastrointestinal haemorrhage, pancytopenia, thrombocytopenia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, FLUDARA. Patient was hospitalized. Patient died on 02/26/2006.
Zevalin Side Effects Report #5504698-6
Zevalin side effect was reported by a Physician from POLAND on Oct 16, 2007. Male patient, 63 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac failure, dehydration, lower gastrointestinal haemorrhage, malignant neoplasm progression, pancytopenia, shock. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, FLUDARA. Patient was hospitalized. Patient died on 02/26/2006.
Zevalin Side Effects Report #5550479-7
Zevalin side effect was reported by a Physician from POLAND on Nov 23, 2007. Male patient, 63 years of age, was diagnosed with mantle cell lymphoma recurrent and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac failure, dehydration, lower gastrointestinal haemorrhage, myocardial ischaemia, pancytopenia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, FLUDARA. Patient was hospitalized. Patient died on 02/26/2006.
Zevalin Side Effects Report #5924071-6
Zevalin side effect was reported by a Health Professional from FRANCE on July 25, 2008. Male patient, 54 years of age, weighting 209.4 lb, was diagnosed with bone marrow conditioning regimen, non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation
, blood creatinine increased, candidiasis, cardiac failure, cardiogenic shock, catheter related infection, cystitis noninfective, dysgeusia. Zevalin dosage: unknown. During the same period patient was treated with MABTHERA, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, ROCEPHIN, AMIKILIN. Patient was hospitalized. Patient recovered.Zevalin Side Effects Report #5989723-0
Zevalin side effect was reported by a Health Professional from SPAIN on Nov 20, 2008. Male patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood albumin decreased, cardiac failure, catheter related infection, corynebacterium infection, haemodialysis, neutropenia, pulmonary oedema, staphylococcal infection
. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, AMPHOTERICIN B, ACYCLOVIR, NEUPOGEN, CYCLOSPORINE, FUROSEMIDE, VANCOMYCIN. Patient was hospitalized. Patient recovered.
Zevalin and cardiac failure 